Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination

J Infect. 2021 Sep;83(3):381-412. doi: 10.1016/j.jinf.2021.05.035. Epub 2021 May 29.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines
  • BNT162 Vaccine